Delivering growth factors for therapeutics

被引:169
作者
Anitua, Eduardo [1 ]
Sanchez, Mikel [2 ]
Orive, Gorka [1 ]
Andia, Isabel [1 ]
机构
[1] Biotechnol Inst I MAS, Victoria 01005, Spain
[2] Unidad Cirugia Arthoscop Mikel Sanchez, Victoria 01005, Spain
关键词
D O I
10.1016/j.tips.2007.10.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The method by which a drug is released can have a significant effect on therapeutic efficacy. The mode of drug delivery is especially relevant when the therapeutic agent is a growth factor because the dose and spatiotemporal release of such agents at the site of injury is crucial to achieving a successful outcome. Here, we highlight delivery technologies designed to facilitate the local and controlled spatiotemporal release of growth factors through the use of biomaterials, 3D micro- or nano-particles, microspheres, gene therapy and PRGF technology. We present some of the most interesting therapeutic applications based on these approaches and, on PRGF technology in particular, in addition to the limitations, future challenges and directions of the field.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 53 条
[1]   Symptomatic dry eye treatment with autologous platelet-rich plasma [J].
Alio, Jorge L. ;
Colecha, Jose R. ;
Pastor, Silvia ;
Rodriguez, Alejandra ;
Artola, Alberto .
OPHTHALMIC RESEARCH, 2007, 39 (03) :124-129
[2]   Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds [J].
Andreopoulos, FM ;
Persaud, I .
BIOMATERIALS, 2006, 27 (11) :2468-2476
[3]   Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities [J].
Anitua, E ;
Sanchez, M ;
Nurden, AT ;
Zalduendo, M ;
de la Fuente, M ;
Orive, G ;
Azofra, J ;
Andia, I .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 77A (02) :285-293
[4]   Autologous platelets as a source of proteins for healing and tissue regeneration [J].
Anitua, E ;
Andia, I ;
Ardanza, B ;
Nurden, P ;
Nurden, AT .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (01) :4-15
[5]  
Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
[6]  
ANITUA E, IN PRESS J BIOMED MA
[7]   The potential impact of the preparation rich in growth factors (PRGF) in different medical fields [J].
Anitua, Eduardo ;
Sanchez, Mikel ;
Orive, Gorka ;
Andia, Isabel .
BIOMATERIALS, 2007, 28 (31) :4551-4560
[8]   New insights into and novel applications for platelet-rich fibrin therapies [J].
Anitua, Eduardo ;
Sanchez, Mikel ;
Nurden, Alan T. ;
Nurden, Paquita ;
Orive, Gorka ;
Andia, Isabel .
TRENDS IN BIOTECHNOLOGY, 2006, 24 (05) :227-234
[9]  
Anitua Eduardo A, 2006, J Oral Implantol, V32, P72, DOI 10.1563/736.1
[10]   Integrated approach to designing growth factor delivery systems [J].
Chen, Ruth R. ;
Silva, Eduardo A. ;
Yuen, William W. ;
Brock, Andrea A. ;
Fischbach, Claudia ;
Lin, Angela S. ;
Guldberg, Robert E. ;
Mooney, David J. .
FASEB JOURNAL, 2007, 21 (14) :3896-3903